Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Keysight Technologies, Inc. (NYSE:KEYS) and recommended buying the same. "Terrific business, niche business," he added.
在CNBC的《瘋狂金錢快閃環節》中,吉姆·克雷默表示他喜歡Keysight Technologies, Inc.(紐交所:KEYS),並推薦購買。他補充道:「業務非常棒,屬於細分市場。」
Supporting his view, JPMorgan analyst Samik Chatterjee, on Dec. 16, upgraded Keysight from Neutral to Overweight and announced a $200 price target.
支持他的觀點,摩根大通分析師薩米克·查特吉於12月16日將Keysight的評級從中立上調至增持,並宣佈價格目標爲200美元。
Shares Views On These Health Care Names
對這些醫療保健公司發表看法
Cramer recommended to wait for ADMA Biologics, Inc. (NASDAQ:ADMA) to come down before pulling the trigger. "I don't have a catalyst," he noted.
克雷默建議在ADMA Biologics, Inc.(納斯達克:ADMA)下跌之前不要出手。他指出:「我沒有催化劑。」
The company's stock has jumped more than 206% over the past year.
該公司的股票在過去一年中上漲超過206%。
"I just think that they should be making money," Cramer said when asked about NovoCure Limited (NASDAQ:NVCR). "Let's see some money made by Novocure and then we can get behind it."
克雷默在被問及Novocure Limited(納斯達克:NVCR)時說:「我只是覺得他們應該賺錢。讓我們看看Novocure是否能賺到錢,然後我們就可以支持它。」
Novocure, meanwhile, on Jan. 13, reported preliminary net revenues for FY2024 of $605.2 million and preliminary net revenues of $161.3 million for the fourth quarter.
與此同時,Novocure在1月13日報告了FY2024的初步淨收入爲60520萬美元,第四季度的初步淨收入爲16130萬美元。
Other Stocks In Focus
關注的其他股票
When asked about Lockheed Martin Corporation (NYSE:LMT), he said, "I do not want to get in the way of the Palantir buzz saw because that's very close to Elon Musk."
當被問及洛克希德馬丁公司(紐交所:LMT)時,他說:"我不想妨礙Palantir的熱潮,因爲那與埃隆·馬斯克非常接近。"
Lockheed Martin, meanwhile, on Jan. 28, reported mixed fourth-quarter 2024 results. The company reported a net sales decline of 1.3% year-over-year to $18.622 billion, missing the consensus of $18.91 billion. LMT reported Adjusted EPS of $7.67, beating the consensus of $6.64.
與此同時,洛克希德馬丁在1月28日報告了2024年第四季度的混合結果。該公司報告淨銷售額同比下降1.3%,至186.22億美元,低於189.1億美元的共識。LMT報告調整後的每股收益爲7.67美元,高於6.64美元的共識。
Price Action:
價格行動:
- Lockheed Martin shares fell 0.7% to settle at $454.36 on Wednesday.
- ADMA Biologics shares gained 1.3% to close at $16.38 during the session.
- Novocure shares fell 0.2% to settle at $25.52 on Wednesday.
- Keysight shares rose 0.2% to settle at $168.33 on Wednesday.
- 洛克希德馬丁的股票在週三下跌0.7%,收於454.36美元。
- ADMA Biologics的股票在交易過程中上漲1.3%,收於16.38美元。
- Novocure的股票在週三下跌0.2%,收於25.52美元。
- Keysight的股票在週三上漲0.2%,收於168.33美元。
- Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
- 吉姆·克萊默:這隻工業股票「絕對優秀」,第一太陽能「非常便宜」
Image: Shutterstock
圖片:Shutterstock
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因